Background: Although various endothelium-dependent relaxing factors (endothelial autacoids) are released upon the elevation of endothelial cytosolic free Ca 2+ concentration (EC [Ca
Background
Vascular endothelium plays an important role in controlling vascular tone by secreting a variety of endotheliumderived relaxing factors (endothelial autacoids), namely NO, prostacyclin (PGI 2 ), and L-NNA/indomethacin-insensitive relaxing factor [1, 2, 3] . In response to various chemical and physical stimuli, an elevation of endothelial cytosolic free Ca 2+ concentration (EC [Ca 2+ ] i ) followed by the activation of calcium-dependent enzymes/channels and the consequent production of endothelial autacoids [4] . Although EC [Ca 2+ ] i appears to mediate the release of endothelial autacoids, the direct relationship between EC [Ca
2+
] i and vascular contractility in intact vessels remains to be established.
Among all three calcium-dependent endothelial autacoids, NO is the primary regulator responsible for the modulation of vascular tone. The administration of NO synthase (NOS) inhibitors increases blood pressure [5] , indicating an important role of NO on the regulation of basal tone. The basal EC [Ca 2+ ] i level in intact rat aorta [6, 7, 8] or in culture (ref. [9] as an example) is less than 100 nmol/L. Studies using purified endothelial NOS or EC membrane fraction indicate that EC NOS may exhibit a basal enzyme activity under an extremely low calcium level [10, 11] , suggesting that EC [Ca 2+ ] i under basal conditions may be too low to regulate the minimal activity of EC NOS. Moreover, it has been reported that isometric contraction induces a calcium-independent activation of endothelial NOS [12] . Nevertheless, the EC [Ca
] i level was not monitored in these studies. Therefore, the role of EC [Ca 2+ ] i level under basal conditions remains ambiguous and still needs to be validated.
Here we reported the development of a novel method that allowed simultaneous measurement of both EC [Ca
] i and vascular displacement in an opened vascular preparation. The goal of this study is to establish a firm relationship between rat aortic EC [Ca 2+ ] i elevation and vascular contractility by using a receptor-mediated agonist (acetylcholine, ACh) and a receptor-independent agonist (ionomycin). Furthermore, similar approaches were carried out under the conditions that either the EC [Ca 2+ ] i was reduced by exposing the specimen to a calcium-free solution, or its elevation was prevented by a calcium chelator pretreatment.
Results
In our system using rat aortic en face preparations, neither EC [Ca 2+ ] i elevation nor vasodilatation was observed during or at the onset of flow. When exposed to phenylephrine (PE), the specimen contracted immediately and reached maximal within a few min without alteration of EC [Ca 2+ ] i (Fig. 1c, initial of agonists are shown at Fig 3. To examine the relative importance of various endothelial autacoids in our system, the preparations were incubated in the presence or absence of a combination of endothelial autacoid inhibitors. The relative contribution of a specific endothelial autacoid was estimated by performing experiments in the presence of the inhibitors of another two endothelial autacoids. The most potent agonist-induced endothelial autacoid in rat aortae appeared to be NO, which by itself was able to contribute agonist-induced vessel dilatation completely. As a comparison, the L-NNA/indomethacininsensitive factor(s) alone resulted in 40% vasodilatation at most, whereas PGI 2 played insignificant role in this system.
When the ACh-evoked increase of EC [Ca

2+
] i was plotted against the extent of corresponding vascular relaxation, the curve was log-linear and it was almost identical to that from ionomycin experiments (Fig. 4) ] i -vasodilatation curves from ACh (Fig. 5a ) or ionomycin ( In order to examine the role of basal EC [Ca 2+ ] i level in the regulation of vascular tone, PE-precontracted vascular preparations were subsequently exposed to the calcium-free solution followed by ACh (Fig. 6 ). As mentioned earlier, when the vascular preparation was exposed to 50 nmol/L PE, it contracted without concomitant endothe- ] i elevation and vasorelaxation (Fig.  6a) . Results from this part of study are summarized in Table 1 . The PE-precontracted aortic en face preparations contracted further (almost 2-fold) by the exposure to a calcium-free solution, whereas the average basal EC [Ca 2+ ] i decrease was about 35 nmol/L. The role of endothelial autacoids in these calcium-free solution effects was further examined by performing similar experiments in the presence of all endothelial autacoid inhibitors (Fig. 6b) . Pretreatment of endothelial autacoid inhibitors prevented further vasoconstriction induced by the calcium-free solution without affecting EC [Ca 2+ ] i depression (table 1, n = 5), indicating that the calciumfree solution-induced vasoconstriction was attributed to the reduction of endothelial autacoids. When endothelium-denuded preparations were used, the vascular tone did not increase by the exposure to calcium-free solution. In denuded preparations, many vessel segments gradually dilated when exposed to the calcium-free solution, possibly due to the delayed reduction of [Ca 2+ ] i level in smooth muscle cells (data not shown). ] i elevation was less than 200 nmol/L (Fig. 7a) completely blocked when the preparations were pretreated with 40 µmol/L of BAPTA-AM (Fig. 7a) ] i elevation and 50% vasorelaxation under normal conditions (Fig. 3b) . However, at the same concentration it failed to evoke any response in the preparations pretreated with 20 µmol/L of BAPTA-AM (Fig. 7b) ] i in vascular tissues are not reported. As a comparison, the fluorescence signal from our optical system only comes from endothelial cells [7] . Moreover, since the fluorescence signal remained strong for hours, this made the characterization of both agonist-induced EC [Ca 2+ ] i elevation and downstream vascular response possible.
In order to investigate whether the EC [Ca
Some previous studies have reported that flow induces endothelial NO synthase phosphorylation or Ca 2+ entry, which in turn leads to the formation of NO and vasorelaxation in rat arterioles and rabbit aortae and coronary arteries [13, 14, 16, 17] . However, endothelial responses to flow may be variable in different vessels or species. Other studies have shown flow-induced vasoconstriction in rat femoral arteries and rabbit resistant arteries [18, 19] . In this study using isolated rat aortae, neither EC [Ca 2+ ] i elevation nor vasodilatation was observed during or at the onset of flow. Thus, the constant flow applied throughout our experiments was not likely to induce a Ca 2+ -indpendent endothelial NO synthase activation.
We hypothesize that EC [Ca
2+
] i may play an integration role in the regulation of vascular tone. A schematic conclusion of present study (Fig. 8) ] i elevation was completely suppressed by pretreatment of 40 µmol/ L BAPTA-AM, the ACh-induced vasorelaxation was inhibited as well (Fig. 7a) ] i reduction (Fig. 6) . Second, it could be completely blocked by the presence of endothelial autacoids inhibitors (Fig. 6) . Third, if the neurotransmitter release from nerve terminals was blocked by exposure to a calcium free solution, the vessel segments should dilate instead. Similarly, if the calcium-free solution affected the smooth muscle cells, the vessel segments should dilate as well. Vessel dilation actually happened when exposed to calcium-free solution for prolonged time periods (data not shown). Therefore, the basal release of endothelial autacoids appeared to be modulated by the basal EC [Ca 2+ ] i level.
Like in many non-excitable cells, the store-operated capacitative calcium entry in ECs is the main mechanism responsible for the agonist-induced calcium entry [21, 22] . Since the ACh-induced vasorelaxation and EC [Ca 2+ ] i elevation were relatively small under calciumfree conditions (Fig. 6a) , calcium influx appeared to be the major source of EC [Ca 2+ ] i elevation and played a major role in modulating the endothelium-dependent vasorelaxation. It is interesting to find that the agonistinduced EC [Ca 2+ ] i elevation, most likely the capacitative calcium entry, was suppressed in the presence of autacoids inhibitors such as L-NNA, indomethacin, or ouabain and barium (Fig 3) . Various factors, including NO, cytochrome P450, membrane potential, and protein tyrosine kinase inhibitors, have been reported to affect the capacitative calcium entry [22] . Our findings support the notion that the effect of endothelial autacoid inhibitors on vasorelaxation might be partially due to the modulation of capacitative calcium entry into endothelial cells.
It has been proposed that NO synthesis can be activated through calcium independent manner during mechanical stretch of cultured human ECs [23] or during isometric contraction of rabbit aortic rings [12] . Although a sustained increase of NO secretion has been observed after mechanical stimulation of cultured ECs [23] 
We used L-NNA and indomethacin as inhibitors of NO, and PGI 2 , respectively. Although others and we have shown that the combination of L-NNA and indomethacin almost completely abolish the ACh-induced vasorelaxation [24, 25] , a 40% of L-NNA/indomethacininsensitive dilatation was observed in this study. Despite the uncertain identity of the 'L-NNA/indomethacin-insensitive factor' here, the ouabain/barium combination could completely block its dilation effect (Figs. 3 and, 5 ). Thus the fact that L-NNA/indomethacin-insensitive dilation contributed to a significant portion of agonist-induced vasorelaxation in the current setup cannot be explained by our choice of inhibitors used. We believe that this discrepancy is largely due to the higher sensitivity of vascular contractility measurement in our current open preparation than in the conventional vessel ring preparation. In the absence of any inhibitors, while ACh at 10 -8 mol/L induced about 35% displacement of opened vessel segment (Fig. 3) , only about 10% tension reduction was observed in vessel rings [24] .
In 
Materials and Methods
Vessel Preparation and Fura-2 Loading
This study was conducted in conformity with the policies and procedures detailed in the "Guide for Animal Care and Use of Laboratory Animals". Male Wistar rats (6-8 weeks old) were anesthetized by ether inhalation, and
Figure 8
Schematic The rings were labeled for 1 hr at room temperature with 10 µmol/L fura-2 AM in the presence of 0.025% pluronic F-127 [8] . In some experiments, the labeling procedure was carried out in the presence of 20 or 40 µmol/L BAPTA-AM for 45 minutes. The excess chemicals were washed away with KrebsRinger solution.
Experimental Setup
The basic experimental setup for endothelial [Ca 2+ ] i measurement was previously described [7] , with some modification during vessel mounting in order to allow simultaneous measurement of vascular endothelial [Ca 2+ ] i and vascular smooth muscle contraction. One side of the longitudinally opened vessel segment was fixed in the direction of blood flow with insect pins. The corners on the opposite side were passively stretched to an optimal tension (4 g) and pinned onto the base plate (Fig. 1a) . Thus, this arrangement allows free vessel movement in response to the addition of vasoactive chemicals. After vessel mounting, the flow chamber was placed on the microscope stage and perfused with KrebsRinger buffer at 30°C under a constant flow rate of 700 µl/min (estimated shear stress 3 dyne/cm 
Determination of In Situ Endothelial [Ca2+]i and Vascular Tone
The calibration of endothelial [Ca 2+ ] i in each preparation was described previously [7] . ] i analysis.
To calculate the vascular displacement, MetaMorph software (Universal Imaging Corporation, PA, USA) was used to trace and analyze a series of images. The fluorescence image was focused sharply, and a particular endothelial cell in the initial image was selected as a location marker. In the presence of a specific concentration of PE, this image was forced to shift inward during experiments. After the marker had reached its final equilibrium location, the total displacement represented the maximal extent of vascular contraction induced by PE. When the preparation was subsequently exposed to either ACh or ionomycin, the marker moved back towards its initial location, indicating vasorelaxation. The extent of vasodilatation was calculated as the percentage of precontraction value.
To validate the experimental procedure for the measurement of vessel contractility, we calculated results acquired from different EC markers located within the same calcium image. Although the displacement value of each marker may vary from point to point, the relative movement at each point was identical when normalized by the maximal pre-contraction displacement at that point. Moreover, if we on purposely focused at the freemoving edge where some smooth muscle cells were exposed, the relative movements were identical when either ECs or smooth muscle cells were used as the marker. Therefore, there was no detectable relative movement between ECs and the smooth muscle cells underneath, indicating that the ECs in our preparation were firmly attached to basement membrane.
Basic Experimental Protocol
An initial series of experiments were performed on aortic en face preparations for the simultaneous measurement of endothelial [Ca 2+ ] i and vasodilatation in the presence of PE. The endothelial calcium image shifted in a dosedependent manner to the cumulatively increasing concentration of PE (Fig. 1b) . The changes in vascular tone were expressed as a percentage of maximal displacement, which was achieved at a PE concentration of 10 µmol/L. Moreover, the endothelial [Ca 2+ ] i was unaltered during the experimentation (Fig. 1c) . The EC 50 of PE was approximately 50 nmol/L; this concentration was thereafter used for the following experiments to test the vascular tone responses to different vasodilators. EC [Ca 2+ ] i and vascular displacement were determined in PE pre-contracted preparation in the presence of cumulative supplement of ACh (a receptor-dependent agonist) or ionomycin (a receptor-independent agonist). In some experiments, various endothelial autacoid inhibitors were applied to evaluate the relative importance of NO, L-NNA/indomethacin-insensitive dilatation, and PGI 2 in our system [27] . To investigate the role of basal EC [Ca 2+ ] i level in regulating the vascular tone, PE-precon-tracted preparations were subsequently exposed to calcium-free buffer in the presence of PE.
Reagents
Reagents for preparing Krebs-Ringer solution were purchased from Merck (Darstadt, Germany). Other reagents were obtained from Sigma (St. Louis, MO, USA).
Statistical analysis
Results were expressed as mean + SEM. Sample sizes were indicated by n. Dose responses of agonist-induced [Ca 2+ ] i elevation were analyzed by ANOVA with a repeated measures design. Differences between two groups were compared by using unpaired Student's t-test with P < 0.05 considered as statistically significant.
